Sign in now to see personalised content appear here.
You can also see your reading history and subscription details on your subscriber page.
Caesar & Loretz is modernising production and warehousing facilities as well as its HQ in Hilden, Germany
At least three selected start-ups will receive strategic and operational advice, as well as financial support of €25,000 in the form of a silent participation
Sterile product filter manufacturers will usually supply a validation guide. However, different fluids can influence the extractables and filtration efficacy compared with standardised tests. Mozamal Nazir, Senior Scientist, Porvair Filtration, explains the need for a simulated filtration process
A pH-responsive polymer gel could create swallowable devices, including capsules for ultra-long drug delivery
Partnership will create tools that could increase the yield and predictability of engineered proteins such as bispecific antibodies to treat a range of diseases
To ensure proper delivery, inhalation products require APIs and carriers to be sized precisely and mixed carefully. Hosokawa Micron reviews the mixing and size reduction technologies available
Several recently approved and pipeline treatments offer improvements in dosing frequency and administration methods, says GBI Research
Patient safety demands strict quality controls for drug manufacturers, but increasing drug shortages have led to new initiatives by the regulatory authorities that aim to streamline the oversight of new drugs, production processes and facility inspections
Shook hands on the deal at ACHEMA
Non-destructive methods of product inspection can be valuable tools for investigating quality issues. Rene P Friedrichs and David M Wright, Reading Scientific Services, offer an inside view on pharmaceuticals and drug delivery devices using X-ray microtomography
Digiline Single 450 Pharma complies with current and forthcoming serialisation regulations
Sharon Johnson, Senior VP, Quality, Product Development & Regulatory Affairs at Catalent, looks at how the newly created US FDA Office of Pharmaceutical Quality aims to prevent quality issues – and therefore drug shortages – arising by establishing a uniform global programme for drug quality